Cardiol Therapeutics Closes $22 Million Bought Deal Offering

CANNANNEW REPORT

Oakville, Ontario–(Newsfile Corp. – May 12, 2021) – Cardiol Therapeutics Inc. (TSX: CRDL) (“Cardiol” or the “Company“), a clinical-stage biotechnology… Read More…..

Excerpt only …
READ MORE BELOW
Source : Cardiol Therapeutics Closes Million Bought Deal Offering

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.